Synapse - Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)

Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD) Meeting Abstract

Authors:	Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Peled, J. U.; Hanash, A. M.; Perales, M. A.; Sauter, C. S.; Shaffer, B. C.; Shah, G. L.; Tamari, R.; van den Brink, M. R. M.; Young, J. W.; Ponce, D. M.; Barker, J. N.
Abstract Title:	Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)
Meeting Title:	2018 BMT Tandem Meetings
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	24
Issue:	3 Suppl. 1
Meeting Dates:	2018 Feb 21-25
Meeting Location:	Salt Lake City, UT
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2018-03-01
Start Page:	S154
End Page:	S155
Language:	English
ACCESSION:	WOS:000425476000202
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2017.12.298
Notes:	Meeting Abstract: 198 -- Meeting date is incorrect in the original publication's table of contents -- Source: Wos